Dexcom
(Nasdaq: DXCM)
announced today that it appointed Rimma Driscoll to its board of directors.
The San Diego-based continuous glucose monitor (CGM) maker made Driscoll’s appointment effective on Aug. 24. She currently serves as EVP and head of global strategy, commercial and business development and global biodevices for Zoetis.
At Zoetis, a leading animal health company and a Fortune 500 member, Driscoll oversees the global business strategy. She manages the execution of commercial launch plans, external business development and integration efforts.
Get the full story at our sister site, Drug Delivery Business News.